In PD, ECM alterations lead to degradation [15,16], inflammation, and the release of molecules [17] like hyaluronic acid (HA) fragments, tenascin, and sulfated proteoglycans, which act as paracrine signals and potential biomarkers for early diagnosis and PD monitoring [18]. This evidence concerns the gene TNC and Parkinson disease.